MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Robotic Assisted Arm Training in Parkinson’s disease rehabilitation: A pilot study

    R. Yadav, S. Shukla (Etawah, India)

    Objective: The aim and objective of this study was to evaluate whether robotic assisted arm training might improve upper limb function in patients with Parkinson’s…
  • MDS Virtual Congress 2020

    Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment

    J. Chandler, R. Nair, E. Ferries, L. Munsie, T. Changamire, N. Patel, K. Biglan (Louisville, KY, USA)

    Objective: The primary goal of this retrospective cohort study was to understand characteristics, healthcare resource use (HCRU) and costs of patients with PD before and…
  • MDS Virtual Congress 2020

    Pareidolias and Cognition in Isolated REM Sleep Behavior Disorder

    L. Honeycutt, J.F Gagnon, A. Pelletier, J. De Roy, J. Montplaisir, R. Postuma (Montreal, QC, Canada)

    Objective: The objective of this study is to investigate the relationship between errors on the pareidolia test and global cognition in patients with REM sleep…
  • MDS Virtual Congress 2020

    Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients

    O. Lucas-Jiménez, N. Ojeda, J. Peña, I. Gabilondo, A. Murueta-Goyena, J.C Gómez-Esteban, R. del Pino, M. Acera, N. Ibarretxe-Bilbao (Bilbao, Spain)

    Objective: The study aimed to investigate apathy subdomains (reward deficiency syndrome, emotional distress, executive function, auto-activation deficit) and cognitive executive functions differences between PD patients…
  • MDS Virtual Congress 2020

    Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers

    S.. Cantarero Duque, J.P Romero (Madrid, Spain)

    Objective: To search for differences in specific components of cognitive processing in Parkinson’s disease (PD) patients with and without impulse control disorders (ICD) in order…
  • MDS Virtual Congress 2020

    Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

    R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)

    Objective: To determine the diagnostic value of circulating miRNAs and the extracellular vesicle proteins for early detection of patients with Parkinson’s disease and mild cognitive…
  • MDS Virtual Congress 2020

    Cortical pathology in Glucocerebrosidase mutation carriers with anxiety: An MRI study

    E. de Natale, H. Wilson, M. Politis (London, United Kingdom)

    Objective: To employ Magnetic Resonance Imaging (MRI) and investigate structural pathology in the cortex of Glucocerebrosidase (GBA) gene mutation carriers. Background: Mutations in the GBA…
  • MDS Virtual Congress 2020

    Genetic risk scores and hallucinations in Parkinson’s disease patients

    C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, V. Dobricic, O.B Tysnes, L. Bertram, G. Alves, J. Sinsheimer, C. Lill, J. Maple-Grødem, B. Ritz (Los Angeles, CA, USA)

    Objective: To examine the overlap of genetic architecture for Alzheimer’s disease (AD), schizophrenia (SZ), and PD with the genetic architecture for the occurrence of hallucinations…
  • MDS Virtual Congress 2020

    Interest of multiplex ligation-dependent probe amplification assay to identify pathogenic mutations in Parkinson’s disease patients

    E. Mutez, M. Swiderski, L. Defebvre, M.C Chartier-Harlin, V. Huin (Lille, France)

    Objective: To evaluate the interest of the MLPA (Multiplex Ligation-dependent Probe Amplification) commercially available kit in the genetic testing in Parkinson’s disease (PD). Background: PD…
  • MDS Virtual Congress 2020

    TET2-mediated Cdkn2A DNA hydroxymethylation in dopaminergic neuronal injury of Parkinson’s disease

    Y.C Wu, TT. Wu, X. Li, T. Liu (Shanghai, China)

    Objective: Studies have shown that 5-hmC modification is the reverse reaction of DNA methylation, and that this process is regulated by TET family hydroxylases, but…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley